Ovid Therapeutics Inc. filed 2 current reports with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-07-08. Between them they name 1 person. Each change below is quoted from the filing and linked to it.
Every change, newest first
Appointed: Charles Carter, Chief Financial Officer
In connection with Mr. Rona's departure, the Company's Board of Directors (the "Board") appointed Charles Carter, the Company's Senior Vice President of Finance and Financial Planning, as the Company's Chief Financial Officer, principal financial officer, principal accounting officer and secretary, effective as of the Separation Date.
Reported
On May 29, 2026, the Board of Directors (the "Board") of Ovid Therapeutics Inc. (the "Company") approved, effective as of June 15, 2026, an increase in the size of the Board and, upon recommendation of the Nominating and Corporate Governance Committee of the Board (the "Nominating Committee"), the appointment of Anna Greka, M.D., Ph.D., as a Class III director of the Company, with her term expiring at the Company's 2029 annual meeting of stockholders.
Find people with the same kind of experience as the Chief Financial Officer at Ovid Therapeutics Inc., with the record behind each one.
Find candidates like Chief Financial Officer at Ovid Therapeutics Inc.New leaders review vendors and budgets in their first months. Get an alert the next time Ovid Therapeutics Inc. is in the news or changes leadership.
Get an alert when Ovid Therapeutics Inc. changes leadershipTools for this story
Each opens in a new tab, filled in for Ovid Therapeutics Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.